Brigham and Women's Hospital
Boston, MA
Not yet accepting
MagnetisMM-30
A Phase 1B, Open-Label Study of Elranatamab in Combination with Iberdomide in Participants with Relapsed Refractory Multiple Myeloma
- Bispecific Antibody
- BCMA
- CD3
- Phase 1
Not yet accepting
Elotuzumab + Iberdomide Post ABECMA
Elotuzumab + Iberdomide + Dexamethasone Post Ide-Cel in RRMM
- Monoclonal Antibody
- SLAMF7
- Phase 1/2
Accepting patients
Light Chain Cast Nephropathy in Myeloma Patients
The Effect of Novel Treatments in Improving Renal Outcomes Among Patients With Light Chain Cast Nephropathy
Not yet accepting
HEME Hospice - Home Transfusion Program
Supportive Transfusion Program for Patients With Hematologic Malignancies: A Cluster Randomized Trial
- Randomization
Accepting patients
Acute Kidney Injury in Myeloma Patients
Biomarkers of AKI in Patients with Multiple Myeloma Receiving Daratumumab: a Pilot Study